News About: Pharm. Industry
Domestic makers struggling to cope with sluggish OTC sales via price increase
Local pharmaceutical manufacturers are poised to increase the prices of their flagship products in a bid to achieve their sales target this year, as rising global prices of crops, oil and other raw materials are weigh...
LG conducts Phase II trials for new antidiabetic agent
LG Life Sciences says it has conducted Phase II trials of its new dipeptidyl peptidase IV (LC15-0444) for the treatment of type II diabetes.
Results of Phase I trial in 90 diabetic patients, conducted in Seoul Nati...
Dong-A gears up for localization in the PhilippinesDong-A Pharmaceutical Co. is putting more and more efforts into localization in a bold step to raise sales of a renowned brand Bacchus in the Philippines soft drink markets.
...
|
Handok, Sanofi-Aventis launch SDM program for diabetic patientsHandok Pharm and Sanofi-Aventis Korea said on March 18 they had a signing ceremony to launch the fifth Staged Diabetes Management (SDM) program under the collaboration with the ...
|
Dongkook wins Korean patent for sustained release formulations of octretide
Dongkook Pharm said on March 18 it won Korean patent for octreotide in sustained release form and its manufacturing method, following its development of octreotide injection last year.
Octreotide (brand name Sandos...
Huons recalls two lots of heparin sodium injection
Huons Corporation is performing a voluntary recall two lots of heparin sodium injections due to incomplete removal of impurities sourced from a Chinese supplier, Yantai Hepu Biological Product Co., the Korea Food and ...
Suspicions mounting over role of KRPIA
Suspicions are growing over the role of the Korea research-based Pharmaceutical Industry Association (KRPIA) as its member companies are overly concerned with importing high-priced medicines only, irrespective of ...
Korean drug makers eyes OTC market
Stimulated by outer negatives affecting Korea's economy, many pharmaceutical firms plan to expand their presence in the domestic OTC market through sales push on field force and price hike.
Pharmaceutical manufactu...
KFDA approves sorafenib for treatment of hepatocellular carcinomaBayer HealthCare announced on March 18 that the Korea Food and Drug Administration has approved its new drug application for an indication for sorafenib (Nexavar) in hepatocellu...
|
Novartis Korea to promote local venture projects
Novartis Korea plans to make its investment on Korea's three venture start-ups this year for joint research and development (R&D) of new drugs and medical technology.
Novartis Korea, the Korea Trade-Investment Prom...
